Here, we analyzed how TRPV1 modulates T cell-mediated inflammatory responses, which include multiple sclerosis (MS), pulmonary inflammation, inflammatory skin diseases or inflammatory bowel diseases (IBD) as well as osteoarthritis (OA) (Figure 4). This evidence concerns the gene TRPV1 and inflammatory bowel disease.